The relationship between cerebrospinal fluid osteopontin level and central nervous system involvement in childhood acute leukemia

Turkish Journal of Pediatrics

Volumn 55, Issue 1, 2013, Pages 42-49

  Incesoy Özdemir, Sonay ^a   Şahin, Gürses ^a   Bozkurt, Ceyhun ^a   Ören, Ayşe Ceyda ^a   Balkaya, Eda ^a   Ertem, Ulya ^a  

^a Dr Sami Ulus Pediatric Research and Training Hospital   (Turkey)

Author keywords

Acute leukemia; Central nervous system; Cerebrospinal fluid; Osteopontin

Indexed keywords

OSTEOPONTIN;

ACUTE LEUKEMIA; ADOLESCENT; ARTICLE; CENTRAL NERVOUS SYSTEM LEUKEMIA; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; SCHOOL CHILD;

ACUTE DISEASE; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA, BIPHENOTYPIC, ACUTE; LEUKEMIA, MYELOID, ACUTE; MALE; NEOPLASM PROTEINS; OSTEOPONTIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; REMISSION INDUCTION;

EID: 84876585571     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lanzkowsky P. Manual of Pediatrics Hematology and Oncology. San Diego: Elsevier Academic Press; 2005: 415-453.
2. Kutluk T. Çocukluk çaǧi{dotless} kanserlerinin epidemiyolojisi. Klinik Gelişim 2007; 20: 5-12.
3. Donald P. Historical perspective. In: Pui CH (ed). Childhood Leukemias. Cambridge: Cambridge University Press; 1999: 3-18.
4. Pui CH, Relling MV, Downing JR. Mechanism of disease: acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535-1548.
5. Wellwood J, Taylor K. Central nervous system prophylaxis in haematological malignancies. Intern Med J 2002; 32: 252-258.
6. Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 2006; 16: 79-87.
7. Haylock DN, Nilsson SK. Osteopontin: a bridge between bone and blood. Br J Haematol 2006; 134: 467-474.
8. Weber GF. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 2001; 1552: 61-85.
9. Wai PY, Kuo PC. Osteopontin: regulation in tumor metastasis. Cancer Metastasis 2008; 27: 103-118.
10. Oldberg A, Franzén A, Heinegård D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 1986; 83: 8819-8823.
11. Wai PY, Kuo PC. The role of osteopontin in tumor metastasis. J Surg Res 2004; 121: 228-241.
12. Fedarko NS, Jain A, Karadag A, Van Eman MR, Fisher LW. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res 2001; 7: 4060-4066.
13. Rittling SR, Chambers AF. Role of osteopontin in tumour progression. Br J Cancer 2004; 90: 1877-1881.
14. Haylock DN, Nilsson SK. Osteopontin: a bridge between bone and blood. Br J Haematol 2006; 134: 467-474.
15. Standal T, Hjorth-Hansen H, Rasmussen T, et al. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica 2004; 89: 174-182.
16. Pui HC. Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. Am Soci Hematol 2006; 1: 142-146.
17. Pui CH, Thiel E. Central nervous system disease in hematologic malignancies: historical perspective and practical applications. Semin Oncol 2009; 36: 2-16.
18. Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol 2008; 9: 257-268.
19. Glantz MJ, Cole BF, Glantz LK, et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 1998; 82: 733-739.
20. Zeiser R, Burger JA, Bley TA, Windfuhr-Blum M, Schulte-Mönting J, Behringer DM. Clinical follow-up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis - a single centre experience. Br J Haematol 2004; 124: 762-768.
21. Hegde U, Filie A, Little RF, et al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood 2005; 105: 496-502.
22. Cario G, Izraeli S, Teichert A, et al. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS. J Clin Oncol 2007; 25: 4813-4820.
23. Wu S, Fischer L, Gökbuget N, et al. Expression of interleukin 15 in primary adult acute lymphoblastic leukemia. Cancer 2010; 116: 387-392.
24. Kersten MJ, Evers LM, Dellemijn PL, et al. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood 1996; 87: 1985-1989.
25. Komada Y, Ochiai H, Shimizu K, Azuma E, Kamiya H, Sakurai M. Shedding of CD9 antigen into cerebrospinal fluid by acute lymphoblastic leukemia cells. Blood 1990; 76: 112-116.
26. Hansen PB, Kjeldsen L, Dalhoff K, Olesen B. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNSinvolvement. Acta Neurol Scand 1992; 85: 224-227.
27. Caudie C, Bancel J, Dupont M, Matanza D, Poitevin F, Honnorat J. CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin. Ann Biol Clin 2005; 63: 631-637.
28. Dagdemir A, Ertem U, Duru F, Kirazli S. Soluble L-selectin increases in the cerebrospinal fluid prior to meningeal involvement in children with acute lymphoblastic leukemia. Leuk Lymphoma 1998; 28: 391-398.
29. Braitch M, Nunan R, Niepel G, Edwards LJ, Constantinescu CS. Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis. Arch Neurol 2008; 65: 633-635.
30. Chowdhury SA, Lin J, Sadiq SA. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis. Arch Neurol 2008; 65: 232-235.
31. Kao CL, Chiou SH, Ho DM, et al. Elevation of plasma and cerebrospinal fluid osteopontin levels in patients with atypical teratoid/rhabdoid tumor. Am J Clin Pathol 2005; 123: 297-304.